Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 91 for “"Cross-presentation"”.

  1. Mechanisms of Cross-Presentation by cDC1s

    … CD8 T cell responses through the process of cross-presentation. During cross-presentation, exogenous protein antigens are taken up by cDC1 and presented on MHCI molecules, allowing for the priming of CD8 T cells during conditions when DCs themselves are not directly infected. The ability to …

    wustl Repository record for Mechanisms of Cross-Presentation by cDC1s (opens in a new tab)

  2. Molecular Mechanisms of Cross-Presentation on HLA-DP84Gly

    … DP. The foundations of antigen processing and presentation on classical HLA-DR alleles are well-established. However, much less is known regarding the differences in these mechanisms in other, less-studied class II subtypes, particularly HLA-DP, several of which are highly prevalent. We here …

    toronto-retro Repository record for Molecular Mechanisms of Cross-Presentation on HLA-DP84Gly (opens in a new tab)

  3. Unraveling mechanisms behind cross presentation during phagocytic signaling

    … are obtained extracellularly via endocytosis. Cross presentation is the link between the two by which external antigens are targeted to the MHC class I pathway. It is generally accepted that particulate antigens are more efficient in this pathway switch. However the reason behind this …

    calgary Repository record for Unraveling mechanisms behind cross presentation during phagocytic signaling (opens in a new tab)

  4. Hsp 70 and hybrid peptides in cross-presentation and vaccinology

    … particularly HSV. Hsp70 has been shown to cross-present or cross-prime exogenous foreign antigen into the MHC class I pathway of antigen presentation, which is dependent upon the proteasome as well as the transported associated with antigen processing. In addition to cross presentation, …

    ut-knoxville Repository record for Hsp 70 and hybrid peptides in cross-presentation and vaccinology (opens in a new tab)

  5. Saponin-based adjuvants: Enhancing cross-presentation to improve cancer immunotherapy

    … which are particularly effective in inducing cross-presentation. Cross-presentation is a process that takes place in certain cells of the immune system and contributes to a stronger immune response after vaccination. How saponins improve cross-presentation is still largely unknown. This thesis …

    radboud Repository record for Saponin-based adjuvants: Enhancing cross-presentation to improve cancer immunotherapy (opens in a new tab) Download PDF for Saponin-based adjuvants: Enhancing cross-presentation to improve cancer immunotherapy (opens in a new tab)

  6. Cross presentation of oral antigens for induction of CD8⁺ T cell responses

    … about how these T cells respond towards the presentation of oral antigens derived from food. Therefore, it is important to understand the mechanisms involved in preventing the induction of harmful CD8⁺ T cell responses towards food derived antigens. For this purpose, CD8⁺ T cells with a …

    ubc Repository record for Cross presentation of oral antigens for induction of CD8⁺ T cell responses (opens in a new tab) Download PDF for Cross presentation of oral antigens for induction of CD8⁺ T cell responses (opens in a new tab)

  7. Cross-Presentation Is A Source of Tumor Antigens For Multiple Myeloma Immunotherapy

    Cross-presentation is an essential bridge between the innate and adaptive arms of the immune system where antigen presenting cells (APCs) prime cytotoxic T cell responses. We have recently identified cross-presentation as a mechanism by which solid tumors present exogenous antigens. We therefore …

    uthsc Repository record for Cross-Presentation Is A Source of Tumor Antigens For Multiple Myeloma Immunotherapy (opens in a new tab)

  8. Molecular Mechanism of WDFY4-Mediated Cross-Presentation by Type 1 Conventional Dendritic Cells

    … immune responses. cDC1s specialize in cross-presentation (XP), or the MHC-I presentation of exogenous antigens, which allows them to prime antigen-specific CD8+ T cells. In classical MHC-I presentation, cytosolic antigens are processed through the endoplasmic reticulum (ER), relying on …

    wustl Repository record for Molecular Mechanism of WDFY4-Mediated Cross-Presentation by Type 1 Conventional Dendritic Cells (opens in a new tab)

  9. Uncovering the Roles of Fes Kinase in Antigen Cross-Presentation and Anti-Tumour Immunity

    … and antigen processing. Fes-deficient BMDCs cross present ovalbumin much better compared to wild type controls, though differences in antigen-specific CD8+ T cells were not apparent. Transwell separation assays confirmed that EVs derived from DCs activate CD8+ T cells independently of …

    queens Repository record for Uncovering the Roles of Fes Kinase in Antigen Cross-Presentation and Anti-Tumour Immunity (opens in a new tab)

  10. Investigating The Role of Quaking In Antigen Uptake and Cross-Presentation By Dendritic Cells

    … cells (APC) due to their superior capability of cross-presenting exogenous antigens to CD8+ T cell for strong adaptive immune responses. They internalize foreign antigens by phagocytosis, endocytosis or macropinocytosis, which are then processed in endosomal compartments and loaded onto MHC Class …

    uthsc Repository record for Investigating The Role of Quaking In Antigen Uptake and Cross-Presentation By Dendritic Cells (opens in a new tab)

  11. Apolipoprotein L 7C Control of Antigen Escape and Cross-Presentation in Classical Dendritic Cells

    Cross-presentation is the essential process that links the detection of innate immune stimuli by dendritic cells to the generation of potent cytotoxic T cell responses against pathogens and cancer. Despite the obvious importance of cross-presentation, the molecular pathways driving …

    calgary Repository record for Apolipoprotein L 7C Control of Antigen Escape and Cross-Presentation in Classical Dendritic Cells (opens in a new tab)

  12. Deciphering the mechanisms of cross-presentation for exogenous ROPs through their interaction with cathepsin S

    … within dendritic cells to promote antigen cross-presentation and an anti-tumour response. ROPs have been designed with the LRMK linker to target cathepsin S, a key mediator in the vacuolar pathway of cross-presentation. However, the contribution of this pathway to ROP processing is …

    oxford Repository record for Deciphering the mechanisms of cross-presentation for exogenous ROPs through their interaction with cathepsin S (opens in a new tab)

  13. SUBUNIT PEPTIDE-ENCAPSULATING NANOPARTICLE HIV VACCINE TARGETING CYTOTOXIC T LYMPHOCYTE ACTIVATION VIA PROTAC-ENHANCED CROSS PRESENTATION

    … pathway, and 4) be loaded onto MHC I for cross-presentation (CP) to CTLs. In this thesis, a novel vaccine is introduced that specifically targets antigens to the proteolysis pathway for amplified CP and augments endosomal escape in a nanoparticulate drug delivery platform. Inspired by …

    jhu Repository record for SUBUNIT PEPTIDE-ENCAPSULATING NANOPARTICLE HIV VACCINE TARGETING CYTOTOXIC T LYMPHOCYTE ACTIVATION VIA PROTAC-ENHANCED CROSS PRESENTATION (opens in a new tab)

  14. Controlling Cross-Presentation of Integrin Binding and BMP Mimicking Peptides to Control Mesenchymal Stromal Cell Fate

    … in this manner, through a heterobifunctional crosslinker (BCN-amine) was more potent than cRGD that was directly grafted to alginate via carbodiimide chemistry. I then sought to increase the potency of the KE peptide. MSC expressed key markers of osteogenesis (RUNX2, Alkaline Phosphatase, ALP …

    wustl Repository record for Controlling Cross-Presentation of Integrin Binding and BMP Mimicking Peptides to Control Mesenchymal Stromal Cell Fate (opens in a new tab)

  15. Anti-Nucleic Acid Antibody-Mediated Cross Presentation of An Antigen and Its CD8+ T Cell Activation

    Cross-presentation is important for initiating cytotoxic T lymphocyte (CTL) responses against tumors. Delivery of exogenous antigens to the cross-presentation pathway in dendritic cells using a number of different carriers has been attempted to further understand the mechanisms underlying …

    ajou Repository record for Anti-Nucleic Acid Antibody-Mediated Cross Presentation of An Antigen and Its CD8+ T Cell Activation (opens in a new tab) Embargoed until 9999-12-31

  16. Characterizing The Source of Neutrophil Elastase and Proteinase 3 Cross-Presentation In B-Cell Acute Lymphoblastic Leukemia

    … leukemia. Our lab reported that NE and P3 are cross-presented by antigen presenting cells (APCs) and solid tumors, a mechanism whereby exogenous antigens are endocytosed and presented on HLA class I molecules, inducing a cytotoxic T lymphocyte (CTL)-mediated immune response. Therefore, …

    uthsc Repository record for Characterizing The Source of Neutrophil Elastase and Proteinase 3 Cross-Presentation In B-Cell Acute Lymphoblastic Leukemia (opens in a new tab)

  17. Radiation-driven cross presentation and STING activation enhance CAR T Cell therapy in a murine lymphoma model

    … T cell transfer therapy validated upregulated cross presentation in the same group. RT induced activation of the cGAS/STING pathway which was directly associated with the enhanced CAR-T cell anti-tumor effects. Overall, these results suggest RT may serve as optimal adjuvant and bridging therapy …

    greece Repository record for Radiation-driven cross presentation and STING activation enhance CAR T Cell therapy in a murine lymphoma model (opens in a new tab)

  18. Use of viral fusion proteins to develop tumour - antigen presenting cell hybrids leading to cross-presentation of tumour antigens

    … and dendritic cell fusions to improve immune presentation of tumour antigens has previously been shown to have a positive effect on tumour regression with no reported cytotoxicity. Building on this, the generation of tumour and antigen-presenting cell (APC) hybrids is a desirable approach that …

    oxford Repository record for Use of viral fusion proteins to develop tumour - antigen presenting cell hybrids leading to cross-presentation of tumour antigens (opens in a new tab)

Page 1 of 5